Human Laminin 521 Protein, Research Grade
产品描述(Product Details)
Laminin 521 offers a defined surface for feeder-free culture of human pluripotent stem cells (PSCs). It maintains normal growth and stemness in ESC, iPSC, and MSC lines. Laminin 521 supports PSC growth for over 10 passages without karyotypic abnormalities and retains differentiation ability into all three germ layers.
This product is specifically designed for academic research applications and is an alternative to basement membrane extract at No Extra Cost.
RG Laminin 521 vs. Basement Membrane Extract
Defined matrix and good lot-to-lot consistency;
Easy to handle (not to handle in 4℃);
Support homogenous monolayer and faster growth;
Avoid cell differentiation;
Cost-effective, comparable pricing to Basement Membrane Extract or Vitronectin.
RG Laminin 521 vs. Vitronectin
Better cell survival in single cell passaging and colony formation;
Better cell adhesion ability during cardiac cell differentiation.
产品参数(Key parameter)

重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 24 months in lyophilized state;
-70°C for 12 months under sterile conditions after reconstitution;
2-8°C for 3 months under sterile conditions after reconstitution.


关键字: Laminin 521;Laminin 521蛋白;Laminin 521重组蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。